Author/Authors :
Rezaie, Nader Department of Pulmonary Disease - Tehran University of Medical Science, Tehran , Shams-Hosseini, Narges Sadat Department of Pulmonary Disease - Tehran University of Medical Science, Tehran , Kashanizadeh, Atefeh Department of Pulmonary Disease - Tehran University of Medical Science, Tehran , Karimi, Mohammad Ali Department of Pulmonary Disease - Tehran University of Medical Science, Tehran
Abstract :
Recent studies investigated on effectiveness of
Ipratropium and Salmeterol — Fluticason (SFC) in
chronic obstructive pulmonary disease (COPD) patients.
Some of these investigations revealed these increased O2
saturation (SaO2) in duration sleep and increased quality
of life.[1,2] Thus, we decided to evaluate and compare
the effect of Ipratropium bromide and SFC on SaO2 in
patients suffered by COPD.